Skip to content

Clinical trials

Observational Neurocognitive Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Phase: Observational Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20193
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jewish General Hospital3
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal1
Olivier Beauchet1
University of Calgary1
University of Manitoba1
Women's College Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders8
Alzheimer Disease2
Aphasia, Primary Progressive1
Cognitive Dysfunction1
Confusion1
Delirium1
Mental Disorders1
Nervous System Diseases1
Neurobehavioral Manifestations1
Neurologic Manifestations1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.